News Conference News EAS 2017 FOURIER in Focus: Costs, Patient Selection, Combination Therapy, and Safety Debated as Lipid Experts Digest the Data Yael L. Maxwell April 26, 2017
News Conference News EAS 2017 Is Atherosclerosis an LDL-Cholesterol or Immune Disease? The Answer May Be Both Yael L. Maxwell April 25, 2017
News Daily News Novel Percutaneous Technique May Allow for TMVR in Patients at High Risk for LVOT Obstruction Yael L. Maxwell April 18, 2017
News Daily News Treating In-Stent CTOs May Be Riskier Than De Novo CTOs Despite Similar Procedural Success Yael L. Maxwell April 17, 2017
News Daily News Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3 L.A. McKeown April 12, 2017
News Industry News Medis Receives CE Certification for Its Image-based Assessment of QFR® for Physiological Assessment of Coronary Obstructions without the Use of Pressure Wire April 12, 2017
News Daily News Score May Ease Risk Stratification in Acute MI-Related Cardiogenic Shock Todd Neale April 10, 2017
News Daily News ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events Michael O'Riordan April 04, 2017
Presentation ECHO 2017 3D-Echocardiographic Guiding of a Novel Transcatheter Mitral Valve Replacement Presenter: Florian Deuschl March 31, 2017
News Daily News Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial Michael O'Riordan March 29, 2017
News Conference News ACC 2017 Simplified MRI Imaging Tests May Help ID Kids at High CV Risk During Sports Michael O'Riordan March 24, 2017
News Conference News ACC 2017 Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them Yael L. Maxwell March 23, 2017
News Conference News ACC 2017 DECISION-CTO: PCI Stumbles for Stable CAD Patients With Chronic Total Occlusions Yael L. Maxwell March 19, 2017
News Conference News ACC 2017 Radiation Exposure Greater for Radial vs Femoral PCI, RAD-MATRIX Dosimeter Study Confirms L.A. McKeown March 19, 2017
News Conference News ACC 2017 CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS Yael L. Maxwell March 18, 2017
News Conference News ACC 2017 Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe Todd Neale March 18, 2017
News Conference News ACC 2017 Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE L.A. McKeown March 18, 2017
News Conference News ACC 2017 ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s Yael L. Maxwell March 17, 2017